A Centers for Disease Control and Prevention panel is set to vote Tuesday on who will be first in line to get the coronavirus vaccine.
The meeting with the Advisory Committee on Immunization Practices, an outside group of medical experts that advises the CDC, comes a day after Moderna requested emergency clearance from the Food and Drug Administration for its Covid-19 vaccine. Pfizer, which is working with German drugmaker BioNtech, applied for that authorization on Nov. 20. U.S. officials expect the first doses of one of the vaccines could be distributed in a few weeks — even before the end of the year.
